# Carmen Merino

Carmen is a Trademark Administrator. She joined the Firm in 2015. She regularly deals with the management of trademarks and designs portfolios before the Spanish Patent and Trademark Office (SPTO), the European Union Intellectual Property Office (EUIPO) and the World Intellectual Property Organization (WIPO) for multinational companies in the EU and worldwide and is in charge of the surveillance department on new TMs published within the Spanish Industrial Property Gazette; EUIPO Gazette and/or WIPO Gazette and of the preparation of the client’s watch alerts.



### Representative matters



- Permanent representation and advice to a **major mobile network** provider in comprehensive portfolio litigation based on several standard-essential patents, in particular with regard to antitrust law and FRAND as well as license negotiations (2015-today)
- Patent representation of a **global tobacco company** and advice on e-cigarettes and coordination with numerous foreign jurisdictions (2018 – today)
- Representing one of the largest companies in the field of **mobile communications** in a multi-country patent infringement case relating to standard-essential and other patents as well as border seizure proceedings at a leading global trade show (IFA) (2014-today)
- Representing one of the **leading Japanese electronics corporation** in a litigation series concerning navigation devices
- Representation of a **mobile phone manufacturer** in arbitration proceedings concerning a patent licensing agreement, taking into account important competition law issues as well as the determination of FRAND license fees (2012-2016)
- Representation of a **nationwide automotive supplier** in patent nullity proceedings and coordination with parallel European and US proceedings (2017-2019)
- Representing a **leading global automotive technology manufacturer** in a comprehensive patent infringement litigation in several countries concerning navigation systems up to the Federal Supreme Court (2011-2012) as well as concerning windscreen wipers (2014) and engine technology (2018-today)
- Representation of a **Japanese multinational in the field of printing technology** (patent infringement and nullity proceedings) (2016-today)
- Representing and advising a **world-renowned household goods company** regarding freedom-to-operate, patent infringement and opposition proceedings (2014-today)
- Representing and advising **a global pharmaceutical company** in preliminary injunction proceedings regarding second medical use claims (2013) and supplementary protection certificates (2017-2018)
- Representation of a **German medical device manufacturer** against several competitors in patent, trademark and design proceedings (2012-2016)



## Professional Affiliations



- Intellectual Property Owners Association (IPO), Member of the Antitrust and European Practice Committees
- European Patent Lawyers Association (EPLAW)
- Licensing Executives Society (LES)
- Association of Intellectual Property Experts (VPP)
- German Association for the Protection of Intellectual Property (GRUR)



## Speaking Engagements



- Regular speaker at the Fordham IP Conference (NYC) on SEPs, FRAND and privateering (2012 – present)
- Symposium PatentForum, Munich, 21. November 2019: “Die FRAND-Verteidigung des Beklagten außerhalb der Mobiltelefonie”
- Association of Danish Intellectual Property Attorneys (ADIPA), Kopenhagen, 5. September 2019: “Right of exemption from the duty to give evidence / Client-Attorney-Privilege”
- Fair Standard Alliance (FSA), Brüssel, 13. März 2019: “FRAND case law in Germany (Europe)”
- Groupe Rhone-Alpes des proprieté industrielle (GRAPI), Lyon, 22. Januar 2019:
- Academy of European Law (ERA), Brüssel, 25. Oktober 2018: “FRAND litigation in the European Union and the USA”
- LES FRANCE, Paris, 3. Juli 2018: “FRAND in Germany”
- DIS 40 Rhein-Ruhr, Düsseldorf, 31. Mai 2017: “Standard-essentiel patents und FRAND since Huawei ./. ZTE”
- IPO European Practice Committee Conference, Frankfurt, 12. Mai 2016: “Admissibility of evidence in Europe obtained through U.S. litigation”
- Licensing Executive Society (LES): Licensing Projects, Presentation of Module I: Introduction to the exploitation of intellectual property rights, 19.02.2016, Stuttgart
- IBC Biotech & Pharmaceutical Patenting 2014, Munich: Second medical use & dosing regimens